Methylated Folate (L-Methylfolate) and MTHFR

Methylated folate (L-methylfolate) is the active form of folate, a B vitamin. The body uses this form, 5-methyltetrahydrofolate (5-MTHF), for methylation. Methylation is the transfer of small chemical tags (methyl groups) from one molecule to another. Most prenatal vitamins and fortified foods contain folic acid instead. Folic acid is a synthetic form of folate. The body must convert it through several steps before it can use it. The enzyme MTHFR performs the final step. It converts folate into methylated folate.

Many people carry common gene variants that slow the MTHFR enzyme. The two best known are C677T and A1298C. These variants do not carry equal weight. C677T slows the enzyme and makes it less stable. People with two copies of C677T have higher blood levels of homocysteine, a byproduct that accumulates when methylation slows.¹ A1298C has a milder effect on the enzyme by itself. It matters most when a person carries one copy of each variant. That combination slows the enzyme more than a single copy of either variant. In people with two copies of the stronger variant, homocysteine tends to rise when folate levels are low.² A slow MTHFR enzyme affects only this final step. The body can still use folic acid for the earlier steps, including making DNA.

High homocysteine can make blood more likely to clot. It may also harm a developing embryo. These effects link MTHFR variants to recurrent pregnancy loss and to the wider group of autoimmune and clotting (thrombophilic) disorders evaluated after repeated pregnancy loss.³

Methylated folate bypasses the MTHFR step because it is already in its active form. Cells can use it regardless of how well MTHFR functions. The next step still requires vitamin B12. Nitrous oxide, a gas used during surgery, temporarily blocks that B12 step. After nitrous oxide, people with two copies of a slow MTHFR variant had a much larger rise in homocysteine than people without one.⁴ For carriers of these variants, methylated folate supplies the active form directly. Folate requirements are highest before conception and in early pregnancy. DNA synthesis and neural tube development are most active during that period. The same pathway also supports sperm production. For this reason, folate and B12 status matter for both partners.

MTHFR variants are common, far more common than rare clotting disorders such as Factor V Leiden. Many carriers have never been tested. Blood tests for homocysteine, folate and B12 show how well methylation is working. Those results answer the clinical question. The genetic result alone does not guide care. Related: thrombophilia, antiphospholipid syndrome.